OPC Pharmaceutical JSC (HOSE:OPC)

Vietnam · Delayed Price · Currency is VND

20,950

-550 (-2.56%)

At close: Jul 24, 2026

4.53% (1Y)

Market Cap	1.57T +4.5%
Revenue (ttm)	1.13T +17.8%
Net Income	95.36B +12.5%
EPS	1,272.55 +6.7%
Shares Out	74.94M
PE Ratio	16.46
Forward PE	n/a
Dividend	683.76 (3.18%)
Ex-Dividend Date	Jul 9, 2026

Volume	4,039
Open	20,000
Previous Close	21,500
Day's Range	20,000 - 21,500
52-Week Range	18,034 - 21,500
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 28, 2026

About OPC Pharmaceutical JSC

OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, hormones, external use, digestion, pain relief, anti-inflammatory, health gifts, and other drugs. It also offers nutritional products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In additi... [Read more]

Industry Pharmaceutical Preparations

Founded 1977

Employees 871

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol OPC

Full Company Profile

Financial Performance

In 2025, OPC Pharmaceutical JSC's revenue was 1.12 trillion, an increase of 15.94% compared to the previous year's 968.58 billion. Earnings were 98.50 billion, an increase of 4.33%.

Financial Statements